Hi-Clearance (1788) - Total Assets
Based on the latest financial reports, Hi-Clearance (1788) holds total assets worth NT$4.99 Billion TWD (≈ $157.20 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hi-Clearance - Total Assets Trend (2015–2024)
This chart illustrates how Hi-Clearance's total assets have evolved over time, based on quarterly financial data. Also see 1788 stock market capitalisation for the company's overall valuation and market capitalisation.
Hi-Clearance - Asset Composition Analysis
Current Asset Composition (December 2024)
Hi-Clearance's total assets of NT$4.99 Billion consist of 50.1% current assets and 49.9% non-current assets. Review 1788 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 8.4% |
| Accounts Receivable | NT$1.02 Billion | 20.5% |
| Inventory | NT$671.68 Million | 13.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Hi-Clearance's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 1788 live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hi-Clearance's current assets represent 50.1% of total assets in 2024, a decrease from 77.1% in 2015.
- Cash Position: Cash and equivalents constituted 8.4% of total assets in 2024, up from 7.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 20.5% of total assets.
Hi-Clearance Competitors by Total Assets
Key competitors of Hi-Clearance based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
Hi-Clearance - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 1.75 | 1.68 |
| Quick Ratio | 1.25 | 1.28 | 1.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.05 Billion | NT$1.08 Billion | NT$899.57 Million |
Hi-Clearance - Advanced Valuation Insights
This section examines the relationship between Hi-Clearance's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.05 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 7.4% |
| Total Assets | NT$4.96 Billion |
| Market Capitalization | $179.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hi-Clearance's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hi-Clearance's assets grew by 7.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hi-Clearance (2015–2024)
The table below shows the annual total assets of Hi-Clearance from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$4.96 Billion ≈ $156.28 Million |
+7.42% |
| 2023-12-31 | NT$4.62 Billion ≈ $145.49 Million |
+2.42% |
| 2022-12-31 | NT$4.51 Billion ≈ $142.05 Million |
+1.60% |
| 2021-12-31 | NT$4.44 Billion ≈ $139.80 Million |
+5.58% |
| 2020-12-31 | NT$4.20 Billion ≈ $132.42 Million |
+12.77% |
| 2019-12-31 | NT$3.73 Billion ≈ $117.42 Million |
+25.52% |
| 2018-12-31 | NT$2.97 Billion ≈ $93.55 Million |
+13.62% |
| 2017-12-31 | NT$2.61 Billion ≈ $82.33 Million |
+5.76% |
| 2016-12-31 | NT$2.47 Billion ≈ $77.85 Million |
+1.64% |
| 2015-12-31 | NT$2.43 Billion ≈ $76.60 Million |
-- |
About Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more